Manus Bio
About Manus Bio
Manus Bio makes nature accessible and affordable for a growing society. Making nature accessible and affordable for a growing society.It is estimated that the world’s population will increase by more than 35% by 2050, reaching 9 billion people. Crop production will need to more than double in order to feed these people and meet the consumer needs of a developing world. With very little land remaining for agricultural expansion, they as a society need to find ways to maximize the use of their world’s resources. Plants produce a variety of rare natural products which are used in their daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. They strive to reduce their dependence on land- and resource-intensive practices by recreating natural processes through biotechnology.
Company Metrics
- Employees: 51-100
- Monthly Visits: None
- Tech Stack: 17 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 98674999 USD
- Last Funding: 2000000 USD (Grant)
- Funding Status: Early Stage Venture
Technology Stack
Manus Bio actively uses 17 products in their tech stack.
Market Presence
Industries: Biopharma, Biotechnology, Food and Beverage
Headquarters: Cambridge, Massachusetts, United States
Leadership
- Ajikumar Parayil - Founder and CEO LinkedIn
Employees
- Brendan Naulty - Chief Commercial Officer (CCO) (LinkedIn)
- Christine Santos - Chief Technology Officer (LinkedIn)
- Jeff Anderson - Chief Business Officer (LinkedIn)
- Jeremy Hux - Chief Financial Officer (LinkedIn)